Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negoro

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Nihon Kyobu Shikkan Gakkai Zasshi|July 1, 1991
[The significance of CA-50, SLX and ST-439 in lung cancer]S Hayasaka, M Takada, T Shinohara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancerN Masuda, M Fukuoka, Y Kusunoki, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|June 1, 1992
[Prognosis of small cell lung cancer with ipsilateral pleural effusion]H Oomori, K Matsui, K Nakagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancerM Fukuoka, H Niitani, A Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1985
[Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer]M Fukuoka, K Furuse, M Takada, et al.
Cancer|April 15, 1990
Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-upM Fukuoka, N Masuda, K Matsui, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Combination therapy with bestatin in inoperable lung cancer. A randomized trialM Takada, M Fukuoka, S Negoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycinM Fukuoka, N Masuda, K Furuse, et al.
Cancer|July 15, 1991
A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancerM Fukuoka, N Masuda, S Negoro, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disordersM Fukuoka, S Negoro, N Masuda, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Nihon Kyobu Shikkan Gakkai Zasshi|July 1, 1991
[The significance of CA-50, SLX and ST-439 in lung cancer]S Hayasaka, M Takada, T Shinohara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancerN Masuda, M Fukuoka, Y Kusunoki, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|June 1, 1992
[Prognosis of small cell lung cancer with ipsilateral pleural effusion]H Oomori, K Matsui, K Nakagawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancerM Fukuoka, H Niitani, A Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1985
[Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer]M Fukuoka, K Furuse, M Takada, et al.
Cancer|April 15, 1990
Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-upM Fukuoka, N Masuda, K Matsui, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Combination therapy with bestatin in inoperable lung cancer. A randomized trialM Takada, M Fukuoka, S Negoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycinM Fukuoka, N Masuda, K Furuse, et al.
Cancer|July 15, 1991
A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancerM Fukuoka, N Masuda, S Negoro, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disordersM Fukuoka, S Negoro, N Masuda, et al.
Pageof 20